NMR spectroscopy and CEST imaging

Revealing Cancer Metabolism In Vivo

Our research group develops non-invasive metabolic and molecular MR techniques using 1H and X nuclei, comprising high-resolution NMR spectroscopy (MRS) and MR spectroscopic imaging (MRSI) at ultra-high fields (B0 ≥ 7T), chemical exchange saturation transfer (CEST) MR imaging, and hyperpolarized carbon-13 (HYP 13C). A particular clinical research focus is the molecular tissue characterization of brain tumors for the stratification of genetic subtypes and the assessment of response to therapies. Another focus is the development of novel imaging techniques for the improved molecular characterization of breast cancers.

Research Topics

  • Imaging of physiological parameters, in particular pH values
  • Assessment of tissues' energy metabolism
  • Assessment of changes in tissues' bulk proteome
  • Identification of imaging surrogates for clinical biomarkers using metabolite signals and molecular contrast mechanisms
  • Development of novel molecular imaging techniques
  • Clinical translation of developed imaging methods

Moreover, our research group is participating in the following consortia projects:

MIRACLE, the platform for virtual biopsies; introducing Metabolic MRI-as-a-Service for oncologic care (HORIZON-EIC funded project)

HYPERBOLIC – Visualizing Hallmarks of Cancer through Tailored Hyperpolarized Magnetic Resonance Imaging (DKTK funded project)

Three-dimensional map showing the intracellular pH value of the brain from a patient with glioblastoma that is derived from a 31P MRSI scan at 7T. The measured signal from the metabolite inorganic phosphate is highly dependent on the intracellular pH value enabling to map pH differences between healthy and diseased tissue

NMR spectroscopy (MRS) enables the detection of signals of atomic nuclei with spin I≠0 bound to biomolecules. The biochemical information is obtained non-invasively and without ionizing radiation.

Several spin species yield multiline in vivo NMR spectra in acquisition times of a few minutes, for example spin-½ nuclei like 1H (information about brain metabolites) and 31P (information about energy metabolism, membrane phospholipid turnover and intracellular pH). The combination of MRS with MR imaging (MRI) techniques is called MR spectroscopic imaging (MRSI), which yields maps of the regional abundance and distribution of metabolites in tissue. 

The introduction of ultrahigh–field (UHF) MR scanners (magnetic field strength B0 ≥ 7 Tesla) opened new perspectives for MRS and MRSI owing to increased sensitivity and spectral resolution, enabling to detect more metabolites. To promote clinical applicability of MRSI, our research group focuses on the development of high-resolution MRSI methods at UHF overcoming several technical challenges occurring at higher fields. 

Contact

3 Employees

  • Dr. Andreas Korzowski

    Group leader

    Contact form: Message to Dr. Andreas Korzowski

    Form data is loaded ...

  • Dr. Philip Boyd

    Project group leader

    Contact form: Message to Dr. Philip Boyd

    Form data is loaded ...

  • Dr. Vanessa Franke

    Project group leader

    Contact form: Message to Dr. Vanessa Franke

    Form data is loaded ...